Tech Launch Arizona

Submit a New Inquiry

Technology #ua17-102 - Mixed MOR/DOR Agonist Activity Provides Improved Analgesic Efficacy and Tolerability for the Treatment of Pathological Pain States Including Pain-Induced Adaptive Changes in the Nervous System

Tech Launch Arizona contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.



By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant